HAP Trading’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-207,300
| Closed | -$132K | – | 2011 |
|
|
2022
Q3 | $132K | Buy |
+207,300
| New | +$11.4M | 0.01% | 723 |
|
|
2022
Q1 | – | Sell |
-26,400
| Closed | -$12K | – | 2968 |
|
|
2021
Q4 | $12K | Buy |
26,400
+16,300
| +161% | +$505K | ﹤0.01% | 2011 |
|
|
2021
Q3 | $5K | Sell |
10,100
-2,300
| -19% | -$67.6K | ﹤0.01% | 2191 |
|
|
2021
Q2 | $12K | Buy |
12,400
+1,500
| +14% | +$58.6K | ﹤0.01% | 1961 |
|
|
2021
Q1 | $15K | Buy |
+10,900
| New | +$501K | ﹤0.01% | 1559 |
|
|
2020
Q4 | – | Sell |
-83,000
| Closed | -$43K | – | 2482 |
|
|
2020
Q3 | $43K | Buy |
+83,000
| New | +$5.27M | ﹤0.01% | 1003 |
|
|
2020
Q1 | – | Sell |
-10,700
| Closed | -$67K | – | 1597 |
|
|
2019
Q4 | $67K | Sell |
10,700
-70,700
| -87% | -$4.19M | ﹤0.01% | 655 |
|
|
2019
Q3 | $114K | Buy |
+81,400
| New | +$4.24M | 0.01% | 589 |
|
|
2019
Q1 | – | Sell |
-105,700
| Closed | -$276K | – | 1448 |
|
|
2018
Q4 | $276K | Buy |
105,700
+62,900
| +147% | +$2.36M | 0.02% | 490 |
|
|
2018
Q3 | $182K | Sell |
42,800
-105,000
| -71% | -$4.65M | 0.01% | 469 |
|
|
2018
Q2 | $828K | Buy |
+147,800
| New | +$6.73M | 0.04% | 265 |
|
|
2017
Q3 | – | Sell |
-26,600
| Closed | -$39K | – | 1131 |
|
|
2017
Q2 | $39K | Sell |
26,600
-65,200
| -71% | -$1.94M | ﹤0.01% | 719 |
|
|
2017
Q1 | $507K | Buy |
+91,800
| New | +$2.31M | 0.03% | 336 |
|
Other funds holding GBT
HAP Trading's GBT Position: Q2 2018 in Review
HAP Trading sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2018, closing a stake of 27,698 shares — an estimated $1.26M sold.
HAP Trading first reported a position in GBT in Q4 2017 and held it in 2 quarters. The position peaked at $1.34M in Q1 2018. 196 funds tracked by Wall St. Rank hold GBT as of Q2 2018.
- HAP Trading reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
- HAP Trading sold 27,698 Global Blood Therapeutics, Inc. shares in Q2 2018, an estimated $1.26M.
- HAP Trading first reported a position in Global Blood Therapeutics, Inc. in Q4 2017 and held it in 2 quarters.
- HAP Trading's Global Blood Therapeutics, Inc. position peaked at $1.34M in Q1 2018.
- 196 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2018.
Based on HAP Trading's 13F filing for Q2 2018, filed 13 Aug 2018.